Coulter Partners places Itta MacNevin as Chief Business Officer of Quibim

Quibim is a global pioneer in imaging biomarkers for precision medicine. The Company’s AI-powered, imaging-based solutions enable pharmaceutical companies to predict which patients will respond to a drug, identify suitable candidates for clinical trials, stratify patients by risk, and accelerate drug development programs. These capabilities are already driving innovation across oncology, immunology and neurology, positioning Quibim as a critical partner in the shift toward more precise, data-driven medicine.

Itta MacNevin brings a proven track record of building and scaling commercial strategies across life sciences, with expertise in driving strategic partnerships, revenue growth and international expansion. In her role as Chief Business Officer, she will lead Quibim’s global commercial strategy within the life sciences sector, overseeing business development, partnerships and go-to-market execution.

Ángel Alberich-Bayarri, CEO and Co-Founder of Quibim, said: “Itta’s appointment comes at a pivotal moment for Quibim as we scale our presence in life sciences and expand our global commercial reach. She brings deep expertise in building high-impact partnerships and translating innovative technology into real-world value. Itta will play a central role in strengthening our relationships with pharmaceutical and biotechnology partners and accelerating the next phase of Quibim’s growth.

“Our partnership with Coulter Partners was excellent throughout this process. Working closely with the Board and executive team, they introduced a global shortlist of candidates, all possessing deep scientific pedigree and commercial strength. Their sector-specific insight was instrumental in helping us navigate this search with speed and precision.”

Ian Coyne, Managing Partner at Coulter Partners, added: “Quibim is at the absolute forefront of imaging biomarker innovation, redefining how we use data to improve patient outcomes. Identifying a CBO who understands the nuances of both digital biomarkers and traditional life sciences was a priority. Itta is a rare talent whose commercial rigor and international perspective make her the ideal fit to help shape the future of Quibim’s platform and global expansion.”

Itta MacNevin, Chief Business Officer at Quibim

Itta MacNevin is a seasoned commercial leader with more than two decades of expertise in the life sciences sector. Prior to joining Quibim, she spent 10 years at Evotec, where she held various senior leadership roles focused on commercial strategy and business development. Before her tenure at Evotec, she spent a decade at Scynexis, where she was instrumental in driving strategic growth and partnerships from the company's early stages.

Throughout her career, Itta has successfully navigated complex ever changing markets and scaled business development teams to meet the needs of global pharmaceutical and biotech clients. She holds a B.S. in Chemistry from the University of Richmond and an M.S. in Organic Chemistry from Emory University.

About Quibim

About Coulter Partners